Edition:
United Kingdom

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

6.11USD
22 May 2018
Change (% chg)

$-0.07 (-1.13%)
Prev Close
$6.18
Open
$6.17
Day's High
$6.17
Day's Low
$6.02
Volume
5,904
Avg. Vol
37,230
52-wk High
$21.59
52-wk Low
$4.78

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.581
FY 2017 Dec '17 0.00 -0.634
Sep '17 0.00 -0.816
Jun '17 0.00 -0.990
Mar '17 0.00 -0.787
FY 2016 Dec '16 0.00 -0.306
Sep '16 0.00 -0.565
Jun '16 0.00 -0.166
Mar '16 0.00 -0.267
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 2 1.10 2.19 0.00 0.00
Year Ending Dec-18 2 2.19 4.38 0.00 0.83
Year Ending Dec-19 2 4.40 8.80 0.00 4.00
Earnings (per share)
Quarter Ending Jun-18 4 -0.57 -0.47 -0.62 -0.77
Quarter Ending Sep-18 4 -0.70 -0.57 -0.97 -0.91
Year Ending Dec-18 4 -2.39 -1.86 -3.05 -2.48
Year Ending Dec-19 4 -2.68 -1.64 -3.64 -3.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 237.88 32.90
P/E High - Last 5 Yrs. -- 288.83 47.21
P/E Low - Last 5 Yrs. -- 98.72 24.78
Beta -- 0.75 0.79
Price to Sales (TTM) -- 259.46 8.29
Price to Book (MRQ) 4.12 24.14 4.33
Price to Tangible Book (MRQ) 4.12 27.11 5.85
Price to Cash Flow (TTM) -- 136.51 21.98
% Owned Institutions 33.25 10.79 2.41

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.65
Dividend Yield - 5 Year Avg -- 0.21 0.80
Dividend 5 Year Growth Rate -- 2.33 4.07
Payout Ratio(TTM) -- 46.75 17.46

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 26.40 4.91
Sales (TTM) vs TTM 1 Yr. Ago -- 148.74 12.76
Sales - 5 Yr. Growth Rate -- 30.74 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 26.24 -92.10 35.43
EPS (TTM) vs TTM 1 Yr. Ago -65.63 -- --
EPS - 5 Yr. Growth Rate -- 48.12 8.55
Capital Spending - 5 Yr. Growth Rate -- 39.30 8.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.53
Current Ratio (MRQ) 5.57 6.54 3.60
LT Debt to Equity (MRQ) 37.28 22.32 12.91
Total Debt to Equity (MRQ) 48.59 25.84 15.97
Interest Coverage (TTM) -19,973.00 -183.81 34.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.84 54.97
Gross Margin - 5 Yr. Avg. -- 55.04 52.78
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -152.46 15.93
Operating Margin (TTM) -- -880.31 0.12
Operating Margin - 5 Yr. Avg. -- -164.95 11.20
Pre-Tax Margin (TTM) -- -766.07 2.20
Pre-Tax Margin - 5 Yr. Avg. -- -169.66 11.41
Net Profit Margin (TTM) -- -757.80 -1.22
Net Profit Margin - 5 Yr. Avg. -- -169.25 7.70
Effective Tax Rate (TTM) -- 14.74 31.30
Effective Tax Rate - 5 Yr. Avg. -- 18.42 24.62

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,123,425 731,572,994
Net Income/Employee (TTM) -1,841,278 -997,531 85,104,893
Receivable Turnover (TTM) -- 17.65 5.75
Inventory Turnover (TTM) -- 2.46 3.58
Asset Turnover (TTM) 0.00 0.42 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -102.48 -5.19 10.07
Return on Assets - 5 Yr. Avg. -- -0.37 11.12
Return on Investment (TTM) -123.03 -7.38 12.74
Return on Investment - 5 Yr. Avg. -- 2.95 14.40
Return on Equity (TTM) -143.74 -10.11 14.64
Return on Equity - 5 Yr. Avg. -- -2.58 15.76
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -25.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gemphire Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 33.24%
# of Holders: 34
Total Shares Held: 4,730,331
3 Mo. Net Change: 1,545,263
# New Positions: 6
# Closed Positions: 9
# Increased Positions: 18
# Reduced Positions: 17
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.